EurekAlert! -
2 Nov 2017 06:00
(Purdue University) On Target Laboratories Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, has secured $40 million in a combination of equity and convertible debt financing.
Share this Article